IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb
NCT00432666
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
148
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-stroke Upper Limb Spasticity
Interventions
DRUG:
IncobotulinumtoxinA (Xeomin)
DRUG:
Placebo
Sponsor
Merz Pharmaceuticals GmbH